Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) FCF Margin (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed FCF Margin for 16 consecutive years, with 12.58% as the latest value for Q3 2025.

  • Quarterly FCF Margin rose 2626.0% to 12.58% in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 3.89% through Sep 2025, up 1906.0% year-over-year, with the annual reading at 13.65% for FY2024, 164.0% down from the prior year.
  • FCF Margin for Q3 2025 was 12.58% at Xtant Medical Holdings, up from 2.57% in the prior quarter.
  • The five-year high for FCF Margin was 12.58% in Q3 2025, with the low at 23.42% in Q1 2024.
  • Average FCF Margin over 5 years is 8.14%, with a median of 11.48% recorded in 2022.
  • The sharpest move saw FCF Margin plummeted -1643bps in 2022, then surged 2626bps in 2025.
  • Over 5 years, FCF Margin stood at 1.45% in 2021, then tumbled by -1129bps to 17.88% in 2022, then soared by 75bps to 4.55% in 2023, then soared by 100bps to 0.02% in 2024, then surged by 56713bps to 12.58% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 12.58%, 2.57%, and 0.26% for Q3 2025, Q2 2025, and Q1 2025 respectively.